Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8148363 Heterocyclic compounds as factor IXA inhibitors

Patent 8148363 was granted and assigned to Schering on April, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Xiaobang Gao0

Yan Xia0

Brian A. McKittrick0

Haiyan Pu0

Henry Vaccaro0

Keith A. Eagen0

Liyuan Wang0

Mariappan V. Chelliah0

...

Date of Patent

April 3, 2012

0

Patent Application Number

129936070

Date Filed

May 18, 2009

0

Patent Citations Received

US Patent 12018003 Substituted pyrimidines as matrix metalloproteinase-9 hemopexin domain inhibitors

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to novel heterocyclic compounds of Formulae I-III; as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8148363 Heterocyclic compounds as factor IXA inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.